Disability improvement in relapsing-remitting multiple sclerosis patients receiving cladribine tablets, evaluated by expanded disability status scale

被引：0
|
作者：
Sormani, M. P. [1 ,2 ]
Giovannoni, G. [3 ]
Signori, A. [1 ]
Alexandri, N. [4 ]
机构：
[1] Univ Genoa, Genoa, Italy
[2] Osped Policlin San Martino, Genoa, Italy
[3] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England
[4] Merck KGaA, Darmstadt, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P0201
引用
收藏
页码：215 / 215
页数：1
相关论文
共 50 条
  • [41] Longitudinal disability curves for predicting the course of relapsing-remitting multiple sclerosis
    Achiron, A
    Barak, Y
    Rotstein, Z
    MULTIPLE SCLEROSIS, 2003, 9 (05): : 486 - 491
  • [42] Alemtuzumab improves Expanded Disability Status Scale functional system scores better than interferon beta-1a in patients with relapsing-remitting multiple sclerosis
    Fox, Edward J.
    MULTIPLE SCLEROSIS, 2009, 15 (11): : 1396 - 1397
  • [43] Effectiveness Of Cladribine Tablets In Patients With Relapsing-remitting Multiple Sclerosis With Baseline EDSS ≥3.5 Or ≤3.0 In CLARITY
    Comi, G.
    Pardo, G.
    Dangond, F.
    Aldridge, J.
    Lemieux, C.
    Rammohan, K.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 42 - 43
  • [44] COST-EFFECTIVENESS ANALYSIS OF CLADRIBINE TABLETS FOR TREATMENT OF PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN BULGARIA
    Djambazov, S.
    Slavchev, G.
    Dineva, T.
    Panayotov, P.
    Vekov, T.
    VALUE IN HEALTH, 2018, 21 : S206 - S206
  • [45] Cladribine Tablets Demonstrate Similar Efficacy In Male And Female Patients With Relapsing-remitting Multiple Sclerosis In CLARITY
    Pardo, G.
    Dangond, F.
    Aldridge, J.
    Lemieux, C.
    Bowen, J. D.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 40 - 40
  • [46] Association Between Cognitive Trajectories and Disability Progression in Patients With Relapsing-Remitting Multiple Sclerosis
    Merlo, Daniel
    Stankovich, Jim
    Bai, Claire
    Kalincik, Tomas
    Zhu, Chao
    Gresle, Melissa
    Lechner-Scott, Jeannette
    Kilpatrick, Trevor
    Barnett, Michael
    Taylor, Bruce
    Darby, David
    Butzkueven, Helmut
    Van der Walt, Anneke
    NEUROLOGY, 2021, 97 (20) : E2020 - E2031
  • [47] The association between disease activity and disability progression in patients with relapsing-remitting multiple sclerosis
    Spelman, T.
    Geale, K.
    Anell, B.
    Hillert, J.
    Wong, S. L.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 127 - 128
  • [48] The prognostic value of initial relapses on the evolution of disability in patients with relapsing-remitting multiple sclerosis
    Binquet, C.
    Quantin, C.
    Le Teuff, G.
    Pagliano, J. F.
    Abrahamowicz, M.
    Moreau, T.
    NEUROEPIDEMIOLOGY, 2006, 27 (01) : 45 - 54
  • [49] Clinical predictors of disability in treatment-naive relapsing-remitting multiple sclerosis patients
    Ivaniuk, A.
    Solodovnikova, I.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 921 - 921
  • [50] Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients with Very Mild Clinical Disability
    Migliore, S.
    Ghazaryan, A.
    Simonelli, I.
    Pasqualetti, P.
    Squitieri, F.
    Curcio, G.
    Landi, D.
    Palmieri, M. G.
    Moffa, F.
    Filippi, M. M.
    Vernieri, F.
    BEHAVIOURAL NEUROLOGY, 2017, 2017
12345